181 related articles for article (PubMed ID: 21310922)
1. Regulation of S100A10 by the PML-RAR-α oncoprotein.
O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM
Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
[TBL] [Abstract][Full Text] [Related]
3. The aberrant fusion proteins PML-RAR alpha and PLZF-RAR alpha contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia.
Müller C; Yang R; Park DJ; Serve H; Berdel WE; Koeffler HP
Blood; 2000 Dec; 96(12):3894-9. PubMed ID: 11090075
[TBL] [Abstract][Full Text] [Related]
4. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
5. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
Chen SJ; Chen LJ; Zhou GB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)
Holloway RW; Thomas ML; Cohen AM; Bharadwaj AG; Rahman M; Marcato P; Marignani PA; Waisman DM
Cell Death Dis; 2018 Sep; 9(9):920. PubMed ID: 30206209
[TBL] [Abstract][Full Text] [Related]
7. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract][Full Text] [Related]
8. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
9. Annexin II and bleeding in acute promyelocytic leukemia.
Menell JS; Cesarman GM; Jacovina AT; McLaughlin MA; Lev EA; Hajjar KA
N Engl J Med; 1999 Apr; 340(13):994-1004. PubMed ID: 10099141
[TBL] [Abstract][Full Text] [Related]
10. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.
Park DJ; Vuong PT; de Vos S; Douer D; Koeffler HP
Blood; 2003 Nov; 102(10):3727-36. PubMed ID: 12893766
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
13. Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.
Grignani F; Gelmetti V; Fanelli M; Rogaia D; De Matteis S; Ferrara FF; Bonci D; Grignani F; Nervi C; Pelicci PG
Oncogene; 1999 Nov; 18(46):6313-21. PubMed ID: 10597230
[TBL] [Abstract][Full Text] [Related]
14. The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia.
Liu Y; Wang Z; Jiang M; Dai L; Zhang W; Wu D; Ruan C
Leuk Res; 2011 Jul; 35(7):879-84. PubMed ID: 21146216
[TBL] [Abstract][Full Text] [Related]
15. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
16. Regulation of fibrinolysis by S100A10 in vivo.
Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
[TBL] [Abstract][Full Text] [Related]
17. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
19. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
20. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
Gu BW; Xiong H; Zhou Y; Chen B; Wang L; Dong S; Yu ZY; Lu LF; Zhong M; Yin HF; Zhu GF; Huang W; Ren SX; Gallagher RE; Waxman S; Chen GQ; Wang ZG; Chen Z; Fu G; Chen SJ
Proc Natl Acad Sci U S A; 2002 May; 99(11):7640-5. PubMed ID: 12032336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
